Anti-tumor immunotherapy despite immunity to adenovirus using a novel adenoviral vector Ad5 [E1-, E2b-]-CEA.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 7, p. 1131, doi. 10.1007/s00262-010-0847-8
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2010 AND VI 59 AND IP 7
Results: 15
1
2
Th17 cells: positive or negative role in tumor?
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 7, p. 979, doi. 10.1007/s00262-010-0849-6
- By:
- Publication type:
- Article
3
( E)-4-Hydroxy-3-methyl-but-2 enyl pyrophosphate-stimulated Vγ9Vδ2 T cells possess T helper type 1-promoting adjuvant activity for human monocyte-derived dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 7, p. 1109, doi. 10.1007/s00262-010-0839-8
- By:
- Publication type:
- Article
4
Induction of tumor-specific acquired immunity against already established tumors by selective stimulation of innate DEC-205<sup>+</sup> dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 7, p. 1083, doi. 10.1007/s00262-010-0835-z
- By:
- Publication type:
- Article
5
Listeria-derived ActA is an effective adjuvant for primary and metastatic tumor immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 7, p. 1049, doi. 10.1007/s00262-010-0830-4
- By:
- Publication type:
- Article
6
The anti-tumor effect of Newcastle disease virus HN protein is influenced by differential subcellular targeting.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 7, p. 989, doi. 10.1007/s00262-010-0821-5
- By:
- Publication type:
- Article
7
A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 7, p. 1001, doi. 10.1007/s00262-010-0822-4
- By:
- Publication type:
- Article
8
Expression of toll-like receptor 4 is down-regulated during progression of cervical neoplasia.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 7, p. 1021, doi. 10.1007/s00262-010-0825-1
- By:
- Publication type:
- Article
9
Characterization of human CD4 helper T cell responses against Aurora kinase A.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 7, p. 1029, doi. 10.1007/s00262-010-0826-0
- By:
- Publication type:
- Article
10
Cytotoxic T lymphocyte epitopes from human heparanase can elicit a potent anti-tumor immune response in mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 7, p. 1041, doi. 10.1007/s00262-010-0829-x
- By:
- Publication type:
- Article
11
Growth inhibition of tumor cells in vitro by using monoclonal antibodies against gonadotropin-releasing hormone receptor.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 7, p. 1011, doi. 10.1007/s00262-010-0823-3
- By:
- Publication type:
- Article
12
Optimized combination therapy using bortezomib, TRAIL and TLR agonists in established breast tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 7, p. 1073, doi. 10.1007/s00262-010-0834-0
- By:
- Publication type:
- Article
13
Antitumor activity of Type I and Type III interferons in BNL hepatoma model.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 7, p. 1059, doi. 10.1007/s00262-010-0831-3
- By:
- Publication type:
- Article
14
Prolonged survival in mice with advanced tumors treated with syngeneic or allogeneic intra-bone marrow–bone marrow transplantation plus fetal thymus transplantation.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 7, p. 1121, doi. 10.1007/s00262-010-0840-2
- By:
- Publication type:
- Article
15
Thrombin facilitates invasion of ovarian cancer along peritoneum by inducing monocyte differentiation toward tumor-associated macrophage-like cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 7, p. 1097, doi. 10.1007/s00262-010-0836-y
- By:
- Publication type:
- Article